Image

Global Ovulation Inducing Drugs Market – Industry Trends and Forecast to 2029

Pharmaceutical

Image

Global Ovulation Inducing Drugs Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Oct 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Ovulation Inducing Drugs Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 3.82 USD Billion
Diagram Market Size (Forecast Year) USD 6.10 USD Billion
Diagram CAGR %

Major Markets Players

  • Novartis AG
  • Endo International
  • Teva Pharmaceutical Industries Ltd
  • Glenmark Pharmaceuticals Ltd
  • Cipla

Global Ovulation Inducing Drugs Market, By Drug Class (Hormones, Therapeutics Drugs), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Ovulation Inducing Drugs Market

Ovulation Inducing Drugs Market Analysis and Size

The global ovulation inducing drugs market is expected to witness significant growth during the forecast period. Changing lifestyle, delayed pregnancy, adverse medicinal effects, and comorbidities led to the higher adoption of in vitro fertilization (IVF) or assisted reproductive treatments worldwide. Physicians insist on removing a maximum number of eggs because of low volatility and high failure rates in fertilization and other IVF procedures. Numerous medications, including pharmaceutical preparations and hormones, are administered to induce ovulation and upsurge egg count. Several developing markets and huge R&D investments are the factors responsible for the growth of this market. COVID-19 also had a major impact on the market growth.

Data Bridge Market Research analyses a growth rate in the g global ovulation inducing drugs market in the forecast period 2022-2029. The expected CAGR of global ovulation inducing drugs market is tend to be around 6% in the mentioned forecast period. The market was valued at USD 3.82 billion in 2021, and it would grow upto USD 6.1 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Anovulation is a type of infertility condition wherein the follicles in the ovary do not mature and release eggs for which ovulation treatment is given. Ovulation induction is a kind of treatment for this condition. Many drugs that fuel the ovary to develop and release eggs can be used to persuade ovulation. Obesity, stress, diabetes, poly cystic ovarian syndrome (PCOS), smoking, and other lifestyle disorders and unhealthy diets are rising, resulting in higher demand for ovulation-inducing drugs.

Ovulation Inducing Drugs Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

 Drug Class (Hormones, Therapeutics Drugs), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Novartis AG (Switzerland), Endo International Inc (Ireland), Teva Pharmaceutical Industries Ltd (Israel), Glenmark Pharmaceuticals Ltd (India), Cipla Inc (India), Dr Reddy's Laboratories Ltd (India), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer Inc (U.S.), Zydus Group (India), Lupin (India), Abbvie Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Serum Institute of India Pvt. Ltd (India)

Market Opportunities

  • Increasing Infertility Cases
  • Increasing Demand for Retail Pharmacies

Global Ovulation Inducing Drugs Market Dynamics

Drivers

  • Growing Research Developments

There has been rising developments in this disease area, boosting the market growth. For instance, Ferring Pharmaceuticals, a biopharmaceutical corporation, purchased the commercialization rights of Ganirelix Acetate Injection from Sun Pharmaceutical Industries Ltd in 2019 for an undisclosed amount. Ferring Pharmaceuticals aims to enlarge its portfolio of reproduction-related medicines as a result of the acquisition. The FDA approved Ganirelix Acetate Injection in 2018 for regulating premature luteinizing hormone (LH) levels in women undergoing fertility treatment. This boosts the market growth.

  • Rising Demand for Therapeutic Drugs

Clomiphene or Clomid tablets are the most extensively used medications to treat these patients. Clomiphene or Clomid tablets fuel follicles and thus egg development by growing the pituitary gland's production of follicle-stimulating hormone (FSH). Clomiphene citrate is preferred more because it is inexpensive, effective when taken orally, has lesser side effects, and is comparatively safe for the foetus.

Opportunities

  • Increasing Infertility Cases

Per the records of the Centers for Disease Control and Prevention (CDC) in 2019, infertility affects around 10% of women between the ages of 15 to 44 years in the US. Additionally, in 2019, in India, 10% to 15% of couples in reproductive age group suffer from infertility. Henceforth, the increasing cases of infertility worldwide is growing the demand for ovulation inducing drugs.

  • Increasing Demand for Retail Pharmacies

The rise in the number of ovulation inducing therapeutics being delivered through retail pharmacies and the increase in the number of retail pharmacies in highly developed countries create opportunities for market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

  • Side Effects of Ovulation Inducing Drugs

There are various side effects of infertility drugs, such as nausea, upper respiratory tract infection, headache, abdominal tenderness, mood swings, acne, breast tenderness, sinus inflammation, weight gain, pelvic discomfort, unexplained bleeding or spotting, vomiting, injection site pain, dizziness, and Ovarian Hyper-Stimulation Syndrome, redness which are restraining the market growth of ovulation-inducing drugs.

  • High Cost

The high cost of IVF procedure and low success rates are the primary factors restraining the global ovulation-inducing drug market.

This global ovulation inducing drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global ovulation inducing drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Ovulation Inducing Drugs Market Scope

The global ovulation inducing drugs market is segmented on the basis of drug class, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Class

  • Hormones
  • Follicle stimulating hormone (FSH)
  • Human menopausal gonadotropin (hMG)
  • Human chorionic gonadotropin (hCG)
  • Therapeutics Drugs
  • Gonadotropin releasing hormone (GnRH) agonists
  • GnRH antagonists

Route of Administration

  • Oral
  • Parenteral
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Ovulation Inducing Drugs Market Regional Analysis/Insights

The global ovulation inducing drugs market is analysed and market size insights and trends are provided by drug class, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global ovulation inducing drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for global ovulation-inducing drugs market throughout the forecasted period due to the rise cases of infertility and the increase in awareness about the ovulation inducing drugs as well as advanced healthcare facilities.

Asia-Pacific dominates the market due to the increase in government initiatives and developing healthcare facilities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Ovulation Inducing Drugs Market Share Analysis

The global ovulation inducing drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global ovulation inducing drugs market.

Key players operating in the global ovulation inducing drugs market include:

  • Novartis AG (Switzerland)
  • Endo International Inc (Ireland)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Glenmark Pharmaceuticals Ltd (India)
  • Cipla Inc (India)
  • Dr Reddy's Laboratories Ltd (India)
  • Abbott (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Pfizer Inc (U.S.)
  • Zydus Group (India)
  • Lupin (India)
  • Abbvie Inc. (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Aurobindo Pharma (India)
  • Serum Institute of India Pvt. Ltd (India)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The global ovulation inducing drugs market was USD 3.82 billion in 2021.
The global ovulation inducing drugs market is projected to grow at a CAGR of 6% during the forecast period of 2022-2029.
Asia-Pacific dominates the market due to the increase in government initiatives and the development of healthcare facilities.
North America has been witnessing positive growth for the global ovulation-inducing drugs market throughout the forecasted period due to the rise cases of infertility and the increase in awareness about the ovulation-inducing drugs as well as advanced healthcare facilities.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials